Progestin-containing Intrauterine System class drugs

8 results
  • balcoltra

    (levonorgestrel and ethinyl estradiol)
    Avion Pharmaceuticals
    Balcoltra is indicated for use in females of reproductive potential for the prevention of pregnancy.
  • climara pro

    (Estradiol and Levonorgestrel)
    Bayer HealthCare Pharmaceuticals Inc.
    Climara Pro is indicated for the treatment of moderate to severe vasomotor symptoms associated with menopause and the prevention of postmenopausal osteoporosis, specifically in women at significant risk. Non-estrogen medications should be considered first for osteoporosis prevention.
  • kyleena

    (Levonorgestrel)
    Bayer HealthCare Pharmaceuticals Inc.
    Kyleena is indicated for the prevention of pregnancy for up to 5 years. If continued use is desired, the device should be replaced after 5 years.
  • liletta

    (Levonorgestrel)
    Allergan, Inc.
    LILETTA is indicated for contraception to prevent pregnancy for up to 8 years and for the treatment of heavy menstrual bleeding for up to 5 years in patients using intrauterine contraception, with replacement required after 5 years if continued treatment is necessary.
  • mirena

    (Levonorgestrel)
    Bayer HealthCare Pharmaceuticals Inc.
    Mirena is indicated for contraception, preventing pregnancy for up to 8 years, and for treating heavy menstrual bleeding for up to 5 years in women using it as their contraceptive method. Replacement is suggested at the end of the respective durations if treatment continues.
  • skyla

    (Levonorgestrel)
    Bayer HealthCare Pharmaceuticals Inc.
    Skyla® is indicated for the prevention of pregnancy for up to 3 years. If continued use is desired, the system should be replaced after this duration.
  • twirla

    (levonorgestrel/ethinyl estradiol)
    Agile Therapeutics, Inc.
    TWIRLA is indicated for contraception in women of reproductive potential with a BMI < 30 kg/m². However, caution is advised for those with a BMI ≥ 25 to < 30 kg/m² due to reduced effectiveness, and it is contraindicated for women with a BMI ≥ 30 kg/m².
  • tyblume

    (Levonorgestrel and Ethinyl Estradiol)
    Exeltis USA, Inc.
    TYBLUME is indicated for females of reproductive potential to prevent pregnancy.